Immunogenicity of dendritic-tumor fusion hybrids and their utility in cancer immunotherapy

Critical Reviews in Immunology
Suyu ShuPeter A Cohen

Abstract

Cancer immunotherapy using fusion hybrid cells generated from dendritic cells (DCs) and tumor cells may be more effective than other DC-based vaccines. DC-tumor fusion potentially confers not only the DCs' antigen-presenting functionality but also a continuing source of endogenous tumor antigens for major-histocompatibility-complex-restricted T-cell sensitization. In animal models, many investigators demonstrated that vaccination with fusion hybrids was protective against tumor challenge and therapeutic, resulting in the regression of established tumors. In clinical trials for patients with a variety of metastatic diseases, fusion hybrid vaccines were well tolerated, but the overall objective response rate was only 10.9%. Careful scrutiny of a large number of publications revealed that, in most cases, no definitive evidence of heterokaryonic fusion cell formation was found. Further corroboration of this conclusion comes from reports that fusion hybrids generated from autologous (syngeneic) and allogeneic DCs displayed equivalent immunological function and therapeutic effects in vitro and in vivo. This puzzling finding suggests that effective fusion immunotherapy depends on tumor antigen scavenging and presentation by antigen-pr...Continue Reading

Citations

Nov 19, 2008·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Yuri V BobryshevReginald V N Lord
May 5, 2011·Journal of Biomedicine & Biotechnology·Shigeo KoidoHisao Tajiri
Jul 31, 2013·The Journal of Surgical Research·Chunrui TanWalter T Lee
Nov 21, 2008·Liver International : Official Journal of the International Association for the Study of the Liver·Gianpiero GravanteDavid M Lloyd
Jan 19, 2011·American Journal of Reproductive Immunology : AJRI·Douglas J HanlonGil Mor
Apr 10, 2010·Journal of Biomedicine & Biotechnology·Shigeo KoidoHisao Tajiri
Nov 5, 2010·Clinical & Developmental Immunology·Shigeo KoidoHisao Tajiri
Jun 19, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Galina V ShurinMichael R Shurin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.